Biological markers that predict clinical recurrence in ductal carcinoma in situ of the breast
- 31 March 2003
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 39 (5) , 622-630
- https://doi.org/10.1016/s0959-8049(02)00666-4
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Risk Factors for Recurrence and Metastasis After Breast-Conserving Therapy for Ductal Carcinoma-In-Situ: Analysis of European Organization for Research and Treatment of Cancer Trial 10853Journal of Clinical Oncology, 2001
- Consistency in the observation of features used to classify duct carcinoma in situ (DCIS) of the breastJournal of Clinical Pathology, 2000
- Pathologists' Agreement With Experts and Reproducibility of Breast Ductal Carcinoma-in-Situ Classification SchemesThe American Journal of Surgical Pathology, 2000
- The Diagnosis and Treatment of Ductal Carcinoma In Situ of the BreastThe Breast Journal, 2000
- Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17Cancer, 1999
- The Influence of Margin Width on Local Control of Ductal Carcinoma in Situ of the BreastNew England Journal of Medicine, 1999
- Predictors of local recurrence after treatment of ductal carcinoma in situCancer, 1999
- Immunohistochemical evaluation of multiple biological markers in ductal carcinoma in situ of the breastEuropean Journal Of Cancer, 1996
- A prognostic index for ductal carcinoma in situ of the breastCancer, 1996
- Overview of the biology and management of ductal carcinoma in situ of the breastCancer, 1994